Granville Capital’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.1M Buy
916
+12
+1% +$12.3K 0.49% 28
2026
Q1
$831K Sell
904
-66
-7% -$66.9K 0.43% 31
2025
Q4
$1.04M Buy
+970
New +$927K 0.55% 29

Other funds holding LLY

Granville Capital's LLY Position: Q2 2026 in Review

Granville Capital increased its Eli Lilly (LLY) stake by 1.3% in Q2 2026, buying an estimated $12.3K and bringing the position to 916 shares worth $1.1M. The position accounts for 0.49% of the portfolio, ranked #28.

Granville Capital first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Granville Capital held 916 shares of Eli Lilly worth $1.1M as of Q2 2026.
  • Granville Capital bought 12 Eli Lilly shares in Q2 2026, an estimated $12.3K.
  • Eli Lilly made up 0.49% of Granville Capital's portfolio in Q2 2026, its #28 holding.
  • Granville Capital first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Granville Capital's 13F filing for Q2 2026, filed 11 Aug 2026.